The Dectin-1 Receptor Signaling Pathway Mediates the Remyelination Effect of Lentinan through Suppression of Neuroinflammation and Conversion of Microglia
Open Access
- 28 December 2022
- journal article
- research article
- Published by Wiley in Journal of Immunology Research
- Vol. 2022, 1-19
Abstract
Demyelinating diseases such as multiple sclerosis (MS) are chronic inflammatory autoimmune diseases and involve demyelination and axonal degeneration. Microglia rapidly respond to changes in the environment by altering morphotype and function during the progressive disease stage. Although substantial progress has been made in the drug development for MS, treatment of the progressive forms of the disease remains unsatisfactory. There is great interest in identifying novel agents for treating MS. Lentinus edodes is a traditional food, which can improve physiological function. Lentinan (LNT), a type of polysaccharide extracted from mushroom Lentinus edodes, is an anti-inflammatory and immunomodulatory agent. Here, we studied the remyelination effects of LNT and its therapeutic target in regulating the functions of neuroinflammation. We found that LNT enhanced remyelination and rescued motor deficiency by regulating dectin-1 receptor to inhibit neuroinflammation and microglial cell transformation. LNT promoted the conversion of microglial cells from the M1 status induced by LPS to the M2 status, enhanced the anti-inflammatory markers IL-10 and BDNF, inhibited inflammatory markers TNF-α and IL-1β, and downregulated the microglia activation and oligodendrocyte and astrocyte proliferation by modulating dectin-1. If we injected the dectin-1-specific inhibitor laminarin (Lam), the remyelination effects induced by LNT were completely abolished. Thus, these results suggest that LNT is a novel and potential therapeutic agent that can rescue MS neuroimmune imbalance and remyelination through a dectin-1 receptor-dependent mechanism.Keywords
Funding Information
- Major Science and Technology Projects in Yunnan Province (202001BB050003, 202101BA070001-071, 202201AT070299, 2019FD136, 31860267)
- National Natural Science Foundation of China (202001BB050003, 202101BA070001-071, 202201AT070299, 2019FD136, 31860267)
This publication has 51 references indexed in Scilit:
- C-Type Lectin-Like Receptors of the Dectin-1 Cluster: Ligands and Signaling PathwaysInternational Reviews of Immunology, 2013
- β-Glucan from Lentinus edodes Inhibits Nitric Oxide and Tumor Necrosis Factor-α Production and Phosphorylation of Mitogen-activated Protein Kinases in Lipopolysaccharide-stimulated Murine RAW 264.7 MacrophagesJournal of Biological Chemistry, 2012
- Syk Kinase-Coupled C-type Lectin Receptors Engage Protein Kinase C-δ to Elicit Card9 Adaptor-Mediated Innate ImmunityImmunity, 2012
- Expression and regulation of toll-like receptors in cerebral endothelial cellsNeurochemistry International, 2010
- Berberine suppresses neuroinflammatory responses through AMP‐activated protein kinase activation in BV‐2 microgliaJournal of Cellular Biochemistry, 2010
- Laminarin-mediated targeting to Dectin-1 enhances antigen-specific immune responsesBiochemical and Biophysical Research Communications, 2010
- Microglial Physiology: Unique Stimuli, Specialized ResponsesAnnual Review of Immunology, 2009
- Remyelination in the CNS: from biology to therapyNature Reviews Neuroscience, 2008
- Differential infection of mononuclear phagocytes by Francisella tularensis: role of the macrophage mannose receptorJournal of Leukocyte Biology, 2006
- Resting Microglial Cells Are Highly Dynamic Surveillants of Brain Parenchyma in VivoScience, 2005